Life Science Angels

Thank you, Scott Barclay, for sharing insights on digital health trends with Stanford University clinicians and scientists. Your expertise and mentorship are truly appreciated. Special thanks to Life Science Angels for sponsoring the event, and to Michael Niaki from StartX and Brian Han from Stanford University School of Medicine for their valuable collaboration.

Exciting News from Neurava! We are thrilled to welcome Daniel Moore and Jed Kay to Neurava’s Board of Directors! Dan Moore, former CEO of Cyberonics and former Chairman of the Board at LivaNova, brings over 35 years of experience in medical devices, with a focus on epilepsy. Jed Kay, an Operating Partner at Elevate Ventures, adds deep experience in commercialization and reimbursement strategies. Their expertise and guidance will be instrumental in driving our mission forward and making a difference for those impacted by epilepsy. #Epilepsy #SUDEP #Neurava #Innovation #MedicalDevices #MedTech

Yesterday, at the NuFund Venture Group General Member Meeting, we hosted our second annual NuFrontier Panel focused on the nuances of early-stage investing. Our three incredible panelists (all NuFund members) brought a wealth of knowledge and experience to the discussion: 🔹 Caitlin Wege  – Former NuFund President who led a pivotal four-year transformation. With decades of experience in early-stage investing across life sciences, manufacturing, and technology, Caitlin has driven impactful innovation and change, shaping NuFund’s current success. 🔹 Denise Saltojanes – Chair of Golden Seed Boston and a leading voice in U.S. early-stage investing. Denise’s engineering background and passion for empowering underrepresented founders add depth to her data-driven approach, making her a standout in the venture space. 🔹 Ohad Tzur – Founder with a successful exit, early team member of a high-growth company, and former Googler. Ohad’s insights on scaling operations, founder-market fit, and data-driven decision-making deeply resonated with the audience. 🎯 Key Takeaways for Early-Stage Investors: 💡 Early-Stage Focus: Start small and diversify to build a balanced portfolio while gaining experience in early-stage investing. 💡 Gut vs. Data: Balance instinct with metrics. Data validates decisions, but gut instinct often identifies founder-market fit and leadership potential. 💡 Market Adaptability: Evolve your investment thesis with market conditions, factoring in interest rates, sector trends, and economic cycles. 💡 Learning Through Collaboration: Engage in due diligence teams to gain hands-on experience and broaden your understanding across industries. 💡 The Power of Community: NuFund’s collaborative network enhances decision-making through shared insights and mentorship. 💡 Evaluating Founders: Look for founders who inspire trust, build strong advisory boards, and articulate a clear vision for long-term success. 💡 Follow-On Funding: Retain your position through follow-on investments to safeguard equity and maintain influence. 💡 Common Pitfalls: Beware of overconfidence in pitches, conduct thorough due diligence, and don’t ignore red flags like misalignment or unclear strategies. 💡 Founder Resilience: Founders who handle tough questions during due diligence often demonstrate the adaptability needed to succeed. 💡 Avoiding Dilution: Plan for follow-on investments to protect equity and maintain a meaningful stake, especially in competitive environments. 👏 Thank You, Caitlin, Denise, and Ohad! Your insights have inspired and better equipped us to navigate the challenges and opportunities in early-stage investing. If you’re a NuFund member, watch the full panel on our Learning Center: https://lnkd.in/gtdW7Ydm #VentureCapital #EarlyStageInvesting #FounderFair #PortfolioBuilding #InvestorInsights #SeedInvest #PreseedFunding

Nervonik, Inc. Completes First-in-Human Clinical Trial of Nerve Stimulation Technology for Chronic Pain Treatment! More details here: https://lnkd.in/gxVjWpRU Tim Deer, MD Aydin Babakhani UCLA #chronicpain #peripheralnervestimulation #PNS

I’m happy to share that I’ve obtained a new certification: VC University. VC University is the certificate course we offer on the fundamentals of venture finance in partnership with National Venture Capital Association and Berkeley Law Executive Education! Thank you to Marc-Henri Galletti for recommending the course!